Jinfu Yang

Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer

Matt I. Gross, Susan D. Demo, Jennifer B. Dennison et al. · Molecular Cancer Therapeutics · 2014 · 1K citations

Glutamine Consumption, Breast Oncology, Antitumor Activity +18

Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)

Han-Jie Zhou, Monette Aujay, Mark K. Bennett et al. · Journal of Medicinal Chemistry · 2009 · 271 citations · Full text

Clinical Pharmacokinetics, Metabolism, and Drug-Drug Interaction of Carfilzomib

Zhengping Wang, Jinfu Yang, Christopher J. Kirk et al. · Drug Metabolism and Disposition · 2012 · 138 citations · Full text

Pharmacokinetics, Pharmacodynamics, Metabolism, Distribution, and Excretion of Carfilzomib in Rats

Jinfu Yang, Zhengping Wang, Ying Fang et al. · Drug Metabolism and Disposition · 2011 · 123 citations

Antitumor Activity Of The Glutaminase Inhibitor CB-839 In Hematological Malignances

Francesco Parlati, Shoshana Bromley-Dulfano, Susan D. Demo et al. · Blood · 2013 · 33 citations